Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice

BACKGROUND: The purpose of this study was to assess the in vivo ability of glucosaminic acid-cobalt (II) chelate to reduce glycemia. METHODS: Different concentrations of chelate solution were administrated to mice with diabetes induced by streptozotocin. RESULTS: Daily oral administration of chelate...

Descripción completa

Detalles Bibliográficos
Autores principales: Talba, Tahirou, Shui, Xia Wen, Cheng, Qinyuan, Tian, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138145/
https://www.ncbi.nlm.nih.gov/pubmed/21779145
http://dx.doi.org/10.2147/DMSO.S18025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138145/
https://www.ncbi.nlm.nih.gov/pubmed/21779145
http://dx.doi.org/10.2147/DMSO.S18025

Ejemplares similares